Capricor Therapeutics Inc (CAPR)

NASDAQ HEALTHCARE

$3.85 -8.11% Daily RSI (14) 11 Oversold As of Jul 31, 2026 Add Alert

Moving Averages

SMA 200

$22.69

Price below

Company Profile

Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$1.25B

P/E Ratio

None

EPS

$-2.32

Beta

0.419